Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 2
2010 7
2011 4
2012 3
2013 5
2015 4
2016 2
2017 4
2018 3
2019 1
2020 6
2021 7
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Percutaneous Coronary Intervention vs Medical Therapy for Coronary Lesions With Positive Fractional Flow Reserve (FFR) but Preserved Pressure-Bounded Coronary Flow Reserve (CFR): A Substudy of the Randomized Compare-Acute Trial.
Haeck JDE, Van't Veer M, Zimmermann FM, Neumann FJ, Triantafyllis AS, Sjauw KD, Abdel-Wahab M, Omerovic E, Boxma-de Klerk BM, Pijls NHJ, Richardt G, Tonino PAL, Johnson NP, Smits PC. Haeck JDE, et al. J Invasive Cardiol. 2021 Jul;33(7):E557-E564. Epub 2021 Jun 5. J Invasive Cardiol. 2021. PMID: 34089578 Free article. Clinical Trial.
Optical coherence tomography guided thrombectomy through a "home-made" aspiration catheter in a young patient with myocardial infarction. To stent or not to stent?
Triantafyllis AS, Kalogeris AN, Haeck JDE, Teeuwen K, Manolis AJ. Triantafyllis AS, et al. Among authors: haeck jde. Postepy Kardiol Interwencyjnej. 2020 Dec;16(4):486-490. doi: 10.5114/aic.2020.101777. Epub 2020 Dec 29. Postepy Kardiol Interwencyjnej. 2020. PMID: 33598025 Free PMC article. No abstract available.
Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo.
Briest F, Koziolek EJ, Albrecht J, Schmidt F, Bernsen MR, Haeck J, Kühl AA, Sedding D, Hartung T, Exner S, Welzel M, Fischer C, Grötzinger C, Brenner W, Baum RP, Grabowski P. Briest F, et al. Among authors: haeck j. Neoplasia. 2021 Jan;23(1):80-98. doi: 10.1016/j.neo.2020.11.004. Epub 2020 Nov 25. Neoplasia. 2021. PMID: 33246310 Free PMC article.
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapy.
Ruigrok EAM, van Vliet N, Dalm SU, de Blois E, van Gent DC, Haeck J, de Ridder C, Stuurman D, Konijnenberg MW, van Weerden WM, de Jong M, Nonnekens J. Ruigrok EAM, et al. Among authors: haeck j. Eur J Nucl Med Mol Imaging. 2021 May;48(5):1339-1350. doi: 10.1007/s00259-020-05057-6. Epub 2020 Oct 23. Eur J Nucl Med Mol Imaging. 2021. PMID: 33094433 Free PMC article.
47 results